文献速递垂体与肾上腺疾病

原发性醛固酮增多症的分子影像学诊疗策略

Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本文综述原发性醛固酮增多症(PA)的定位诊断策略,指出肾上腺静脉采血(AVS)是判断醛固酮分泌侧别的现行金标准,但技术难度大,阻碍及时诊治。文章通过不同病例场景比较AVS与11C-美托咪酯PET-CT(11C-MTO PET-CT)的效用,提出其解读的实用方法并展示临床决策过程。

要点

  • AVS是判断醛固酮分泌侧别的现行金标准,但技术挑战大。
  • 11C-MTO PET-CT等分子影像有望补充现有诊断路径。
  • 单侧腺瘤可行肾上腺切除术,双侧增生以药物治疗为主。

核心结论

  • 分子影像学如11C-MTO PET-CT有潜力补充现有诊断路径并优化PA治疗策略。

研究设计与样本

  • 综述,通过不同病例场景比较AVS与11C-MTO PET-CT的效用,并提出实用解读方法。

主要发现

  • AVS技术挑战对及时诊断和治疗构成显著障碍,改进的分子影像模态可望弥补这一不足。

临床怎么用

  • 对PA患者可结合AVS与11C-MTO PET-CT的结果进行解读,辅助判断单侧或双侧病变以指导手术或药物治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A common yet underdiagnosed cause of secondary hypertension, primary aldosteronism (PA) is characterized by excess aldosterone production, causing hypertension with increased risk of cardio-renal-metabolic complications. Accurate and timely localization of the source of aldosterone excess is crucial for management, in the form of curative adrenalectomy for unilateral aldosterone-producing adenoma or medical management for bilateral adrenal hyperplasia. The current diagnostic algorithm involves adrenal vein sampling (AVS) as the current "gold standard" in determining lateralization of aldosterone secretion, but its technical challenges present significant barriers to timely diagnosis and treatment. Recent technological advancements have contributed to the evolution of molecular imaging modalities such as 11C-metomidate positron emission tomography-computed tomography (11C-MTO PET-CT). Improved molecular imaging modalities hold significant potential to complement existing diagnostic pathways and refine treatment strategies for PA. This review evaluates different case scenarios comparing the utility of AVS with 11C-MTO PET-CT, suggesting a practical approach for its interpretation and highlighting the clinical decision-making process.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Teo AED, Tran HTN, Khoo CM, et al. Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging. J Clin Endocrinol Metab. 2025. PMID: 40690719. doi:10.1210/clinem/dgaf396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。